Tag: Avance

North Carolina, USA & Adelaide, Australia, Apr 19, 2024 – (ACN Newswire) – Avance Clinical, the award-winning North American and Australian market-leading CRO for biotechs, will attend World Orphan Drug Conference in Boston (April 23-25, 2024) to share their rare diseases drug development expertise with biotechs (booth #730). Avance Clinical CEO, Yvonne Lungershausen said that Avance Clinical is dedicated to advancing research and ensuring faster access to therapies that can make a significant difference in patients’ lives.   “Avance Clinical has deep therapeutic knowledge of this area, completing over 50 trials in rare and orphan diseases globally in the last five years, ... Read more

Adelaide, Australia & North Carolina, USA, Oct 19, 2023 – (ACN Newswire) – Avance Clinical, the Australian and North American market-leading CRO for biotechs, was asked to present their GlobalReady drug development solution to more than 45 Korean biotechs and pharmaceutical companies in Seoul, Korea last week as part of a special symposium at KoNECT Korea Conference.  Dt & SanoMedics Chairman, Charles Park (Park, Chae Gyoo) and Avance Clinical CEO Yvonne Lungershausen co-hosting the Global Clinical Trial Strategy Symposium in Korea last week. Avance Clinical’s Korean CRO partner Dt & SanoMedics initiated the Global Clinical Trial Strategy Symposium and invited ... Read more

Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence.Avance Clinical has undergone significant expansion in recent years, including new offices in Sydney and Melbourne to accommodate the growing clinical team in Australia. The award winner will be announced on 1 September 2022. The finalists are:– Avance Clinical– Calyx– CMIC Group– EPS– ICON– Parexel– Syneos Health Avance Clinical’s CEO Yvonne Lungershausen said: “Avance Clinical is extremely pleased to be selected as a finalist for this prestigious award. It is ... Read more

The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for its Phase 1 vaccine clinical trial.Tetherex Pharmaceuticals, Inc. is a privately held, clinical stage biopharmaceutical company focused on development of selectin inhibitor therapeutics for the treatment of a broad range of inflammatory diseases and single-cycle adenovirus vaccines for multiple infectious diseases and cancer indications. Avance Clinical Chief Scientific Officer Dr Gabriel Kremmidiotis said: “The exciting aspect of the Tetherex product is the potential to vaccinate using a nasal spray. Administering ... Read more

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as part of their presence at BIO Digital 2021. Results from the survey found:– 21% were not aware Australian data is accepted by the FDA and other major regulatory authorities– less than half of respondents were aware of Australia’s 43.5% rebate on clinical research spend– only 52% knew that studies could achieve regulatory approval in under 5 weeks in Australia The survey was sent to Endpoints News subscribers in ... Read more